About me
- Assistant Professor of Pediatrics (Gastroenterology, Hepatology and Nutrition) at the Children's Hospital of Philadelphia
Education and training
- Medical School: Kansas City University of Medicine and Biosciences
- Residency: Children's Mercy Hospital
- Fellowship: Children's Hospital of Philadelphia
My Locations
CHOP Specialty Care, Lancaster
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Lancaster General Hospital: Has privileges to treat patients in the hospital.
Qualifications and experience
- Pediatrics/GI (AMA)
- American College of Lifestyle Medicine, National
- American Gastroenterology Association, National
- Crohn's and Colitis Foundation, National
- North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, International
Treatments and Conditions
My research
Flibotte J, Dalembert G, Albenberg L, Bamat T, Barnes A, Carroll B, Nathanson J, Rezet B, Szalda D, Washington N, Weiss A, Ronan JC. Informing differentiated training for pediatric residents in the new ACGME landscape: guidance through a survey of subspecialty faculty. , Association of Pediatric Program Directors Annual Spring Meeting, Atlanta, GA: 2025
Mitchel EB, Dolinger MT, Constant B, Wang Z, Guisado D, Gao M, Fusillo S, Baldassano RN, Kelsen J, Dubinsky M, Huang J, Albenberg L. Ustekinumab is safe and effective in pediatric patients with Crohn's disease , J Pediatr Gastroenterol Nutr: 2025,doi: 10.1002
Breton J, Tu V, Tanes C, Wilson N, Quinn R, Kachelries K, Friedman ES, Bittinger K, Baldassano RN, Compher C, Albenberg L. A pro-inflammatory diet is associated with growth and virulence of Escherichia coli in pediatric Crohn's disease , J Crohns Colitis: 2025,doi: 10.1093
Lachman D, Orlanski-Meyer E, Lev-Tzion R, Ledder O, Assa A, Shavit-Brunschwig Z, Yerushalmi B, Aloi M, Griffiths AM, Albenberg L, Bar-Or I, Kolho KL, Shouval DS, Cohen S, Turner D, Atia O. Long-term outcome of pediatric acute severe colitis: A prospective 5-year follow-up of the PRASCO trial , J Pediatr Gastroenterol Nutr: 2024,doi: 10.1002
Lewis JD, Daniel SG, Li H, Hao F, Patterson AD, Hecht AL, Brensinger CM, Wu GD, Bittinger K; DINE-CD; SPARC IBD Investigators. Surgery for Crohn's Disease Is Associated With a Dysbiotic Microbiome and Metabolome: Results From Two Prospective Cohorts , Cell Mol Gastroenterol Hepatol, 18(3): 2024,101357
Joel MA, Cooper M, Peebles R, Albenberg L, Timko CA. Clinical characterization of Co-morbid autoimmune disease and eating disorders: a retrospective chart review , Eat Disord, 32(4): 2024,353-368
Kennedy KV, Umeweni CN, Alston M, Dolinsky L, McCormack SM, Taylor LA, Bendavid A, Benitez A, Mitchel E, Karakasheva T, Goh V, Maqbool A, Albenberg L, Brown-Whitehorn T, Cianferoni A, Muir AB. Esophageal Remodeling Correlates With Eating Behaviors in Pediatric Eosinophilic Esophagitis , Am J Gastroenterol, 119(6): 2024,1167-1176
Daniel D, Wu GD, Walters W, Compher C, Ni J, Delaroque C, Albenberg L, Ley RE, Patterson AD, Lewis JD, Gewirtz AT, Chassaing B Human Intestinal Microbiome Determines Individualized Inflammatory Response to Dietary Emulsifier Carboxymethylcellulose Consumption , Cell Mol Gastroenterol Hepatol, 17(2): 2024,315-318
Leiby A, Albenberg L, Langseder A, Kennedy M, Pressman N, Chiu S, Rosh JR. A prospective, controlled multisite trial of yoga in pediatric inflammatory bowel disease , J Pediatr Gastroenterol Nutr, 78(2): 2024,272-279
Constant BD, Albenberg L, Mitchel EB, De Zoeten EF, Clapp JT, Scott FI; PRIOR AUTHORIZATION IMPACT NETWORK STUDY GROUP. Prior Authorizations Delay Therapy, Impact Decision-making, and Lead to Adverse Events in Inflammatory Bowel Disease: 2022 Provider Survey , Clin Gastroenterol Hepatol, 22(2): 2024,423-426